ENDRA Life Sciences Inc. — Director's Dealing 2020

Apr 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2020-04-09

Reporting Person: Tokman Alexander Y (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-09	Common Stock	A	42857	$0.00	Acquired	42857	Direct

Footnotes

F1: Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director
Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day
of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2: Includes unvested restricted stock units.